ANDREW REARDON plan to sell securities of LIGAND PHARMACEUTICALS INCORPORATED under Form 144

ANDREW REARDON filed Form 144 to notify SEC of plan to sell 10000 units of LIGAND PHARMACEUTICALS INCORPORATED securities around 2026-07-01, with aggregate market value of $3,160,900.00. The total outstanding units is 20041061.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months include: On 06/01/2026, sold 5000 units for $1135315.50; On 05/01/2026, sold 5000 units for $1156555.50;